A guide to selecting high-performing antibodies for Rab10 (UniProt ID: P61026) for use in western blot, immunoprecipitation, and immunofluorescence
F1000Research · 2024
DOI: 10.12688/f1000research.156209.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2024. Verfasst von Vera Ruíz Moleón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H…. Hauptthemen laut MEDLINE: rab GTP-Binding Proteins, Immunoprecipitation, Blotting, Western, Fluorescent Antibody Technique. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs, Ontario Genomics, Genome Canada.
Abstract (Originalsprache)
Rab10 is a small GTPase involved in cargo transport from the trans-Golgi network to the plasma membrane and endocytic recycling back to the cell membrane. It has garnered significant interest in neurodegenerative disease research, particularly due to its phosphorylation by the LRRK2 kinase. This relationship underscores the importance of Rab10 in cellular processes related to disease pathology, specifically Parkinson’s disease. The accessibility of renewable and selective antibodies against Rab10 would advance research efforts, enabling further understanding of its function and implications in disease. Here, we have characterized eight Rab10 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Québec, H3A 2B4, Canada.
ORCID-Profile: Vera Ruíz Moleón, Charles Alende, Kathleen Southern, Carl Laflamme
Förderung
- Mitacs
- Ontario Genomics
- Genome Canada
- Genome Quebec
Zitieren
APA
Ruíz Moleón, V., Alende, C., Fotouhi, M., Southern, K., Ayoubi, R., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF consortium (2024). A guide to selecting high-performing antibodies for Rab10 (UniProt ID: P61026) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.156209.1
Vancouver
Ruíz Moleón V, Alende C, Fotouhi M, Southern K, Ayoubi R, Laflamme C, et al. A guide to selecting high-performing antibodies for Rab10 (UniProt ID: P61026) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2024. doi:10.12688/f1000research.156209.1
BibTeX
@article{RuzMolen2024,
author = {Ruíz Moleón, Vera and Alende, Charles and Fotouhi, Maryam and Southern, Kathleen and Ayoubi, Riham and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF consortium, ABIF consortium},
title = {A guide to selecting high-performing antibodies for Rab10 (UniProt ID: P61026) for use in western blot, immunoprecipitation, and immunofluorescence},
journal = {F1000Research},
year = {2024},
doi = {10.12688/f1000research.156209.1}
}
EUVIMED